EN
Home/United Arab Emirates/Compare/Wegovy pill vs Wegovy injection: what is the difference in the UAE?
AEUnited Arab Emirates Medicines

Wegovy pill vs Wegovy injection: what is the difference in the UAE?

Same medicine, two forms: the trials, side effects, daily or weekly routine, official prices, and the diabetes versions.

GLP Guidebook teamPublished 14 Oct 20268 min read15 sourcesWritten from published sources
What we checked15 sources, each one opened and linked to the sentence it supportsLast checked 14 Oct 2026 · Next review due 14 Apr 2027 · How we write

Written for the United Arab Emirates. Other country versions are coming.

The short answer

Both contain semaglutide. The pill is taken every day on an empty stomach; the injection once a week. No trial has compared them directly: in separate trials, people lost 13.6% on the 25 mg pill over 64 weeks and 14.9% on the 2.4 mg injection over 68 weeks. Side effects are the same kind, mostly nausea.

Wegovy pill vs Wegovy injection at a glance

At a glanceWegovy pillWegovy injection
Medicine and makerSemaglutide, by Novo Nordisk1Semaglutide, by Novo Nordisk2
Approved in the UAE forLong-term weight management in adults with obesity, or overweight with a weight-related condition; also to lower heart risk in adults with heart disease. Approved June 20263,4Weight management (registered for obesity); Daman also lists it for a scarring fatty-liver disease (MASH). The 7.2 mg dose is not approved here5,6,7
How you take itOne tablet every day on an empty stomach, with a sip of water (up to 120 ml), then 30 minutes with no food, drink or other tablets1One injection under the skin once a week, any time of day, with or without meals2
Dose steps1.5 mg, then 4 mg, 9 mg and 25 mg, at least a month on each10.25 mg, then 0.5, 1 and 1.7 mg, 4 weeks each, then 2.4 mg from week 172
Main trial: weight, and the harm beside itOASIS 4, 64 weeks: −13.6% on 25 mg vs −2.2% on dummy tablets. Nausea in 47 in 100 vs 19 in 1001STEP 1, 68 weeks: −14.9% on 2.4 mg vs −2.4% on dummy injections. Nausea in 44 in 100 vs 16 in 100 in the 68-week trials2
Most common side effectsVery common (more than 1 in 10) on the UK label: nausea, vomiting, diarrhoea, constipation, stomach pain, indigestion, headache, tiredness1Very common (more than 1 in 10) on the EU label: nausea, vomiting, diarrhoea, constipation, stomach pain, headache, tiredness2
Official price, a month and a yearAED 779 (1.5 or 4 mg), 1,199 (9 mg) or 1,610 (25 mg) for 30 tablets. At 25 mg: about AED 1,628 a month, AED 19,535 a year8AED 743.50 (0.25 or 0.5 mg), 1,145.50 (1 mg), 1,440 (1.7 mg) or 1,712 (2.4 mg) for a pen of 4 weekly doses. At 2.4 mg: about AED 1,855 a month, AED 22,256 a year8
Cover in the UAEDubai’s basic plan excludes weight-loss medicines; Daman covers obesity medicines only inside the Thiqa obesity programme9,6The same rules9,6

A month is 364÷12 days and a year 364 days, as in our cost calculator; our arithmetic. Prices from Abu Dhabi’s official drug list, effective 2 Oct 2026. Not a ranking.

Key takeaways

  • No trial has compared the Wegovy pill with the Wegovy injection; their own trials gave 13.6% over 64 weeks and 14.9% over 68 weeks.1,2
  • Nausea was common with both forms: 47 in 100 people on the 25 mg pill and 44 in 100 on the injection, against 16 to 19 in 100 on dummies.1,2
  • The Wegovy pill is taken daily on an empty stomach with a 30-minute wait, while the injection is given once a week at any time.1,2
  • At the maintenance doses, Abu Dhabi’s official prices are AED 1,610 for 30 pills of 25 mg and AED 1,712 for a pen of four 2.4 mg doses.8
On this page
  1. At a glance
  2. Are the Wegovy pill and the injection the same medicine?
  3. Does the pill work as well as the injection?
  4. Are the side effects different?
  5. How different is the routine?
  6. What does each form cost in the UAE?
  7. What about Rybelsus and Ozempic?
  8. Pill or injection: what does a doctor weigh?
  9. Questions people ask
  10. How we researched this

Are the Wegovy pill and the injection the same medicine?

Yes. Both contain semaglutide, made by Novo Nordisk. The pill is a daily tablet at much higher doses, because only about 1 to 2% of a swallowed dose reaches the blood.1,2

Before you go further
  • GLP‑1 medicines are prescription-only in the UAE and should only be used under medical supervision.10
  • Label facts come from the UK label for the tablets and the EU label for the injection, named each time. We could not find the UAE leaflets online.
  • Prices are official prices to the public. We name no pharmacy or clinic and rank nothing by price.
  • Every risk is in Guide 5: Side effects and risks. Nothing here promises a result.

The medicine is what works in your body; the brand is the name on the box. Paracetamol is a medicine, and Panadol is one brand of it. Semaglutide is sold here under four brand names:6,8

  • Wegovy injection (FlexTouch pen), for weight.6
  • Wegovy pill, for weight, approved in the UAE on 1 June 2026.3
  • Ozempic (pen) and Rybelsus (tablets), for type 2 diabetes.6

The doses are not interchangeable: 25 mg in a daily tablet is not the same as 25 mg injected. The UK tablets label says the effect of switching “cannot easily be predicted”, because absorption from tablets varies more.1

Does the pill work as well as the injection?

No trial has compared them directly. In separate trials, people lost 13.6% on the 25 mg pill over 64 weeks and 14.9% on the 2.4 mg injection over 68 weeks.1,2

How these trials work:

  • People are split into groups at random.
  • One group takes the medicine; the other takes a dummy (a placebo) that looks the same.
  • Everyone gets the same advice on diet and activity.
  • The gap between the groups is what the medicine added.
Average weight change in each form’s own trial
Separate trials, different people and lengths. The numbers can’t be compared directly.
Wegovy pill 25 mg · OASIS 4 · 64 weeks · 307 adults
Medicine−13.6%
Dummy−2.2%
Wegovy injection 2.4 mg · STEP 1 · 68 weeks · 1,961 adults
Medicine−14.9%
Dummy−2.4%
Sources: UK Wegovy tablets label, Table 2; EU Wegovy label, Table 4. Checked 14 Oct 2026.

For someone who starts at 100 kg (220 lb), 13.6% is about 14 kg (30 lb) and 14.9% about 15 kg (33 lb). These are averages: some people lose much more, some very little.1,2

  • Pill: 76 in 100 people lost at least 5%, against 31 in 100 on dummy tablets. Put the other way, about 24 in 100 did not.1
  • Injection: 84 in 100 lost at least 5%, against 31 in 100 on dummy injections. About 16 in 100 did not.2

Are the side effects different?

They are the same kind, since it is the same medicine: mostly nausea, vomiting, diarrhoea and constipation, worst while the dose goes up.1,2

  • Nausea: 47 in 100 on the pill against 19 in 100 on dummy tablets; 44 in 100 on the injection against 16 in 100.1,2
  • Vomiting: 31 in 100 on the pill against 6 in 100; 25 in 100 on the injection against 6 in 100.1,2
  • Stopping for good because of stomach effects: about 3 in 100 on the pill and 4 in 100 on the injection.1,2
  • Hair loss: 6.4 in 100 on the pill against 2.0 on dummy tablets; 2.5 in 100 on the injection against 1.0.1,2

These come from separate trials, so small gaps between the two forms may not be real differences.

RisksThe risks, in brief
  • Stomach effects are very common (more than 1 in 10) on both labels.1,2
  • Dehydration from vomiting or diarrhoea can harm the kidneys.1,2
  • Pancreatitis (a swollen, inflamed pancreas) is uncommon, 1 in 100 to 1 in 1,000; gallstones are common, 1 in 10 to 1 in 100, on both labels.1,2
  • Low blood sugar is more likely if you also take insulin or a sulphonylurea.1
  • Not in pregnancy. Stop either form at least 2 months before a planned pregnancy.1,2
Full detail in Guide 5: Side effects and risks →
Get help now: call 998 for an ambulance, or 999.11 Call for severe stomach pain that won’t go away, or vomiting or diarrhoea that stops you keeping fluids down. Call too for a swollen face or trouble breathing.1,2

How different is the routine?

The pill is every morning with strict rules; the injection is once a week at any time. Heat matters more for the pen.1,2

  • Pill: after at least 8 hours without food, swallow it whole with up to half a glass of water, then wait 30 minutes before eating, drinking or taking other tablets.1
  • Injection: once a week into the belly, thigh or upper arm, with or without food.2
  • Missed dose: skip a missed pill and take the next one the following day. A missed injection can be given within 5 days; after that, skip it.1,2
  • Storage: the UK label sets no temperature limit for the tablets. An injection pen in use lasts 6 weeks below 30 °C or in a fridge.1,2

UAE summers go far above 30 °C. Our post on storing pens in the heat covers cars and deliveries, and GLP‑1s in Ramadan covers timing around Suhoor and Iftar.

ToolWhat would a year cost?

The cost calculator uses the same official Abu Dhabi prices, dose by dose, for the months you choose.

Open the calculator

What does each form cost in the UAE?

Prices are fixed nationally. At the maintenance doses, 30 pills of 25 mg cost AED 1,610 and a pen of four 2.4 mg doses costs AED 1,712.8

  • Pill: AED 779 for 30 tablets of 1.5 or 4 mg, AED 1,199 at 9 mg and AED 1,610 at 25 mg.8
  • Injection: AED 743.50 for a pen of 0.25 or 0.5 mg doses, AED 1,145.50 at 1 mg, AED 1,440 at 1.7 mg and AED 1,712 at 2.4 mg. Each pen holds 4 weekly doses.8

A 30-tablet pack lasts 30 days and a pen lasts 28. A year at the maintenance dose comes to about AED 19,535 for the pill and AED 22,256 for the injection, by our arithmetic. Doctor visits and tests are extra.8

Most people pay themselves. Dubai’s basic plan excludes weight-loss medicines, and Daman covers them only inside the Thiqa obesity programme.9,6 More in GLP‑1 prices in the UAE.

What about Rybelsus and Ozempic?

They are the diabetes versions of the same medicine: Rybelsus is the tablet and Ozempic the weekly injection. Daman lists both for type 2 diabetes.6

  • Rybelsus: 3 mg a day for 30 days, then 7 mg, and 14 mg if blood sugar needs more control (US label). AED 641 for 30 tablets at every strength.12,8
  • Ozempic: 0.25 mg a week for 4 weeks, then 0.5 mg, then 1 or 2 mg if needed (EU label). AED 743.50, 1,146 or 1,550 a pen, by strength.13,8

The US Rybelsus label has its own instructions for moving from semaglutide injections to tablets; a doctor follows them.12 Prices for each are in Rybelsus price in the UAE and Ozempic price in the UAE.

Pill or injection: what does a doctor weigh?

A doctor decides, and this page doesn’t recommend either form. In Abu Dhabi, the obesity-certified doctor decides when to start a medicine.14

Things a doctor may weigh:

  • Your mornings: whether you can keep the pill’s empty-stomach rules every day.1
  • Needles: whether a weekly injection suits you.2
  • Other tablets you take in the morning, because of the pill’s 30-minute wait.1
  • Heat and travel: pens in use must stay below 30 °C.2
  • Moving between forms: the UK label says people on the 2.4 mg injection can move to the 25 mg tablet a week after their last injection, but the effect is hard to predict.1

The rules on who can be considered differ by emirate. Abu Dhabi’s standard starts at BMI 30 with a weight-related condition, or over 40.14 Dubai’s guideline allows BMI over 30, or 27 to 29.9 with a condition, after lifestyle changes alone haven’t worked.15 See Guide 6 for prescriptions.

Questions people ask

Is the Wegovy pill as strong as the injection?

No trial has compared them directly. In separate trials, the 25 mg pill gave 13.6% weight loss over 64 weeks and the 2.4 mg injection 14.9% over 68 weeks.1,2

Why is the pill dose so much higher?

Only about 1 to 2% of a swallowed dose reaches the blood, the UK label says, so tablets need far more semaglutide. The doses can’t be swapped mg for mg.1

Can I switch from Wegovy injections to the pill?

The UK label says people on the 2.4 mg injection can move to the 25 mg tablet a week after the last injection, though the effect is hard to predict. Your doctor decides.1

Is the Wegovy pill the same as Rybelsus?

Same medicine, different use and doses. Rybelsus is for type 2 diabetes at 3, 7 or 14 mg; the Wegovy pill is for weight, up to 25 mg.6,12,1

Does the Wegovy pill need a fridge?

No. The UK label sets no special storage temperature for the tablets; keep them in the blister. Pens in use must stay below 30 °C.1,2

How we researched this

On 14 Oct 2026 we read the UK label for Wegovy tablets (OASIS 4), the EU label for the Wegovy injection (STEP 1 and its side-effect figures), the EU Ozempic label and the US Rybelsus label. UAE approvals come from dated UAE news reports and Novo Nordisk’s release; cover rules from Daman, the Dubai basic plan and Abu Dhabi’s health department.

Prices are the official “package price to public” on Abu Dhabi’s drug list, effective 2 October 2026, never a seller’s price. Monthly and yearly figures are our arithmetic, done the same way as our cost calculator.

Before you move on

  • Same medicine, semaglutide, in two forms.
  • No head-to-head trial: 13.6% on the pill, 14.9% on the injection, in separate trials.
  • Pill daily on an empty stomach; injection weekly at any time.
  • Prices are fixed; a doctor decides which form fits.
Side effects and risksConsidering it for weightWegovy pill price

More from the UAE blog

AEUnited Arab EmiratesWegovy pill in the UAE AEUnited Arab EmiratesStoring GLP‑1 pens in UAE heat AEUnited Arab EmiratesGLP‑1 prices in the UAE
About GLP Guidebook

The monthly UAE update

An independent guide to GLP‑1 medicines. We don't sell medicines, take drug-company money or earn clinic commissions. Once a month: UAE approvals, official price changes, insurance rules and safety alerts. How we write

Was this page easy to understand?

Sources

  1. Novo Nordisk. Wegovy tablets (oral semaglutide): UK summary of product characteristics, electronic Medicines Compendium, last updated 16 June 2026, sections 4.1, 4.2, 4.5, 4.6, 4.8, 5.1 (OASIS 4, Table 2), 5.2 (absolute bioavailability about 1–2%) and 6.4. UK label: the UAE leaflet is not published online. medicines.org.uk
  2. European Medicines Agency. Wegovy (semaglutide): EU summary of product characteristics and package leaflet (EU label), sections 4.1, 4.2 (dose steps; missed dose within 5 days), 4.6 (stop at least 2 months before a planned pregnancy), 4.8, 5.1 (STEP 1, Table 4; STEP 8, Table 9), 5.2 (half-life about 1 week) and 6.3 (in use: 6 weeks below 30 °C or in a refrigerator). Not the UAE label. ema.europa.eu (PDF)
  3. Khaleej Times. UAE approves Wegovy pill for weight loss, cardiovascular risk reduction (approved by the Emirates Drug Establishment for “long-term weight management in adults with obesity or overweight linked to weight-related medical conditions”). 1 June 2026. khaleejtimes.com
  4. Novo Nordisk. Wegovy pill launches in the UAE (launch 3 June 2026; “the first country outside the United States to make the Wegovy pill available”; also approved to reduce the risk of major heart events in adults with heart disease and obesity or overweight). Company press release, via BioSpace. biospace.com
  5. Dubai Health Authority. Ejada KPIs and Recommendations: Obesity and Metabolic Syndrome, issued 3 September 2024 (semaglutide (Wegovy) and tirzepatide (Mounjaro) “registered for obesity pharmacotherapy in UAE”). isahd.ae (PDF)
  6. Daman (National Health Insurance Company). Adjudication guideline: Glucagon-like Peptide-1 (GLP‑1) Receptor Agonist, version 5, effective 15 January 2023, revised 19 April 2026: section 3.1.2 (obesity medicines covered under Thiqa for patients enrolled in the Thiqa obesity programme); section 3.3 (obesity medicines “not covered for members who are not enrolled in the Thiqa Obesity Program”); Table 1 (Saxenda/Fitura and Wegovy for obesity; Rybelsus and Ozempic for type 2 diabetes). damaninsurance.ae (PDF)
  7. Gulf News. Higher maintenance dose of weight-loss drug Wegovy approved in EU: when will UAE get it? (“discussions with UAE regulators are ongoing, though no timeline has been set”). 2 March 2026. gulfnews.com
  8. Department of Health – Abu Dhabi. Shafafiya drug price list (Drugs.xlsx), released 26 September 2026, effective 2 October 2026: official “Package Price to Public” for each pack named here, each listed as a prescription-only medicine (“POM”). Downloaded and checked 12 October 2026. shafafiyaportal.doh.gov.ae (XLSX)
  9. Cigna. Essential Benefits Plan (Dubai Health Authority basic plan), table of benefits: exclusion 9 includes “pharmacological weight reduction regimens”; medicines “As per DHA formulary” with a maximum benefit of AED 2,500. cigna-me.com (PDF)
  10. Department of Health – Abu Dhabi. Circular 48/2026, 16 March 2026: alert on counterfeit weight-loss products that falsely claim to contain GLP‑1 medicines, relaying an Australian (TGA) advisory; GLP‑1 medicines “are prescription-only medicines and should only be used under medical supervision”; the products are not registered with the Emirates Drug Establishment but are sold online and on social media; products bought online may be fake, contain undisclosed ingredients or give no medical benefit; report to [email protected]. Summarised, not reproduced, as the circular asks. doh.gov.ae (PDF)
  11. Department of Digital Ajman. Handling emergencies: 999 police, 998 ambulance, 997 civil defence; Ministry of Health and Prevention hotline 80011111 for fake or harmful medicines. Checked 12 October 2026. ajman.ae
  12. US Food and Drug Administration label for Rybelsus (semaglutide tablets), DailyMed, revised 1/2026: type 2 diabetes; section 2.2 (3 mg once daily for 30 days, then 7 mg; 14 mg from day 61 if more glucose control is needed); section 2.4 (instructions for switching from semaglutide injections to tablets). US label, not the UAE label. dailymed.nlm.nih.gov
  13. European Medicines Agency. Ozempic (semaglutide): EU summary of product characteristics and package leaflet, sections 4.1 (type 2 diabetes) and 4.2 (0.25 mg weekly for 4 weeks, then 0.5 mg; then 1 mg and 2 mg if needed). Not the UAE label. ema.europa.eu (PDF)
  14. Department of Health – Abu Dhabi. Standard for Non-Surgical Management of Obesity, DOH/ST/HPS/Non-Surgical-MO/V1/2025, February 2025: section 3.4.2 (GLP‑1 medicines from BMI 30 with a weight-related condition, or over 40; “Continue beyond 6 months only if the patient has lost at least 5% of their initial body weight”; “The obesity certified physician determines the initiation time of pharmacological treatment”). doh.gov.ae (PDF)
  15. Dubai Health Authority. Clinical Guidelines for Virtual Management of Obesity, DHA/HRS/HPSD/CG-53, issue 2, effective 21 April 2024 (medicines can be considered at BMI over 30, or 27 to 29.9 with a condition, after lifestyle changes alone have not worked). dha.gov.ae (PDF)

Last checked 14 Oct 2026 · Next review due 14 Apr 2027 · Report an error

How this page was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical advice. Talk to a qualified doctor or pharmacist before starting, stopping or changing any medicine. How we write